We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New drug and biologic product approvals, 2005.
- Authors
Traynor, Kate
- Abstract
The article reports on the approval of new molecular entities and biological products by the U.S. Food and Drugs Administration. Nelarabine from GlaxoSmithKline PLC was approved for the treatment of T-cell acute lymphoblastic leukemia. Amylin Pharmaceuticals Inc. released two hormone analog products for patients with diabetes mellitus. A new inactivated influenza virus vaccine from GlaxoSmithKline PLC was licensed.
- Subjects
UNITED States; DRUG approval; DRUG development; THERAPEUTICS; AMYLIN Pharmaceuticals Inc.; GLAXOSMITHKLINE; UNITED States. Food &; Drug Administration
- Publication
American Journal of Health-System Pharmacy, 2006, Vol 63, Issue 4, p304
- ISSN
1079-2082
- Publication type
Article
- DOI
10.2146/news050052